Thursday May 25th 2017

Archive for October, 2011

MS patient doesn’t see miracle after surgery

MS patient doesn’t see miracle after surgery

Barrie’s Spencer Ross is back to work after heading to the United States recently for CCSVI surgery, but his Multiple Scleroris symptoms are still there. Ross was on a waiting list for the Chronic Cerebral Spinal Venous Insufficiency (CCSVI) in Albany, New York, but his [Read More]

Montel Williams discusses controversial MS treatment

Montel Williams discusses controversial MS treatment

Having spent much of his adult life coping with multiple sclerosis and trying various medical options, former talk show host Montel Williams decided an experimental — and controversial — treatment was worth the risk: liberation therapy. “The only way I can [Read More]

Letters: Thank Dr. McDonald for MS treatment

Letters: Thank Dr. McDonald for MS treatment

Thank you Dr. Sandy McDonald. Finally, someone is taking the bull by the horns and is actually going to properly investigate this ‘liberation’ treatment. I have had multiple sclerosis for the past 29 years and was lucky enough to undergo the treatment in New [Read More]

 Page 1 of 4  1  2  3  4 »

Latest Topics

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of [Read More]

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

US-based biopharmaceutical firm Celgene has reported positive results from the Phase III RADIANCE clinical trial of [Read More]